Emerging fungal infections in cancer patients

Journal of Hospital Infection

Volumn 33, Issue 2, 1996, Pages 109-117

  Krcmery Jr , V ^a,b  

^a TRNAVA UNIVERSITY   (Slovakia)

^b NONE   (Slovakia)

Author keywords

Antifungal therapy; Cancer patients; Fungal infections; Immunosuppression

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; HEMOPOIETIC GROWTH FACTOR;

CANCER; CANDIDIASIS; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; REVIEW;

EID: 15844429132     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(96)90095-X     Document Type: Review

References (50)

1. Ajello C. Hyalohyphomycosis and pheohyphomycosis. Eur J Epidemiol 1986; 2: 241-251.
2. Annaisie E, Bodey GP. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989; 8: 320-323.
3. Kunova A, Trupl J, Krcmery V Jr. et al. Candida glabrata and C. krusei surveillance in National Cancer Institute in 1989-1994. No association with fluconazole. Chemotherapy. 1995; 42: 1-23.
4. Fincher R. Acremonium infections in compromised hosts. Medicine 1991; 80: 849-851.
5. Leibowitz E. Systemic candidal infection with the use of peripheral venous catheter in neonates. Clin Infect Dis 1992; 14: 485-491.
6. Maartens G, Wood MJ. The clinical presentation and diagnosis of invasive fungal infection. J Antimicrob Chemother 1991; 28: (Suppl. A) 13-22.
7. McQuillen D, Zingmann B, Meunier F, Lewitz S. Ten cases of Candida krusei infections that include 3 cases of endophthalmitis. Clin Infect Dis 1992; 14: 422-426.
8. Richardson MD. Opportunistic and pathogenic fungi. J Antimicrob Agents 1991; 28: (Suppl. A) 1-11.
9. Dube M, Heseltine PN, Rinaldi M, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994; 19: 77-82.
10. Weitzman I. Saprophytic molds as agents of cutaneous and subcutaneous infections in the compromised host. Arch Dermatol 1982; 122: 1161-1168.
11. Sycova Z, Krcmery V Jr. Blastoschizomyces capitatus fungemia in compromised patients. J Hosp Infect 1992; 3: 141.
12. Marinova I, Krcmery V Jr, Sabadosova, V. Rhodotorula rubra fungemia in a boy after neurosurgery. Chemotherapy 1994; 40: 243.
13. Sorkovska D, Sufliarsky J, Kunova A, Krcmery V Jr. Hansenula anomala catheter associated fungemia. Med Rev 1995; 42: 1; 82.
14. Spanik S, Krcmery V Jr. Aureobasidium mansoni meningitis. Case report. Chemotherapy 1993; 39: 4; 321.
15. Krcmery V Jr. Trichosporon beigelii and Candida krusei breakthrough fungemia despite prophylaxis of itraconazole. Eur J Clin Microb Infect Dis 1995; 14: 2; 43.
16. Krcmery V Jr, Kridl J, Trupl J. Torvlopsis glabrata renal abscess with fungemia treated with fluconazole. Clin Infect Dis 1994; 14: 1, 33.
17. Agh F, Spanik S, Horvath A, Krcmery V Jr. Three fatal cases of mucormycosis. Infection 1992; 19: 1; 74.
18. Trupl J, Jesenska Z, Krcmery V Jr. Acremonium infections in compromised hosts. Report of two cases. J Hosp Infect 1993; 3: 142.
19. Mardiak J, Krcmery V Jr. Three cases of fatal Fusarium solanii infection in leukemic patients and review. Clin Infect Dis 1993; 13: 10, 741.
20. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-1277.
21. Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17: 1018-1021.
22. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother 1993; 37: 1847-1849.
23. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida krusei fungemia (letter). N Engl J Med 1991; 325: 1315.
24. Casasnovas RO, Caillot, D, Solary E, et al. Prophylactic fluconazole and Candida krusei infection (letter). N Engl J Med 1992; 326: 891-892.
25. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-851.
26. Winston DJ, Chandrasekar PH, Lazarus HM et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomised placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993; 118: 495-503.
27. Iwen P, Kelly D, Reed E, Hinrichs S. Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. Clin Infect Dis 1995; 20: 342.
28. Rex J, Rinaldi MG, Pfaller MA. Resistance of Candida spp. to fluconazole. Antimicrob Agents Chemother 1995; 39: 1-8.
29. Dick JD, Merz WG, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980; 18: 158-63.
30. Merz WG, Sanford GR. Isolation and characterisation of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol 1979; 9: 677-80.
31. Pappagianis D, Collins MS, Hector R, Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 1979; 16: 123-6.
32. Guinet R, Chanas J, Goullier A, Bonnefoy G, Ambroise-Thomas P. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol 1983; 18: 443-4.
33. Merz WG. Candida lusitaniae: frequency of recovery, colonisation, infection, and amphotericin B resistance. J Clin Microbiol 1984; 20: 1194-1195.
34. Dick JD, Rosengard BR, Merz WG et al. Fetal disseminated candidiasis due to amphotericin B resistant Candida guilliermondii Ann Intern Med 1985; 102: 67-68.
35. Hadfield TL, Smith MB, Winn RE. Mycoses caused by Candida lusitaniae. Rev Infect Dis 1987; 9: 1006-1012.
36. Christenson JC, Guruswamy A, Mukwaya G, Rettig PJ. Candida lusitaniae: an emerging human pathogen. Paediatric Infect Dis J 1987; 6: 755-757.
37. Powderly WG, Kobayashi GS, Herzig GP, Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 1988; 84: 826-832.
38. Kockovska D. Distribution of fungal organisms from sputum in a general hospital in 1984-1994. Bratislava Med J 1995; 75: 89.
39. Hrdy D, Nassav N, Rinaldi MG. Traumatic joint infection due to Geotrichum candidum. Clin Infect Dis 1995; 20: 468-469.
40. Spanik S, Krcmery V Jr. Breakthrough Trichosporon pullulans fungemia in neutropenic patients using prophylaxis with itraconazole. Eur J Clin Microbiol Infect Dis 14; 1995; 9: 699.
41. Warnock DW, Johnson EM. Clinical manifestation and management of uncommon forms of fungal infections in the compromised patients. In: Fungal Infection in the Compromised Patient. 2nd ed., eds D. W. Warnock & M. D. Richardson, J. Wiley & Sons: Chichester 1991; 247.
42. Rex J, Pfaller MA and the Candidemia Study Group. Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients. Antimicrob Agents Chemother 1995; 39: 40-41.
43. Wingard J. Importance of Candida other than Candida albicans. Clin Infect Dis 1995; 20: 115.
44. Todeschini L. Oral itraconazole plus intranasal amphotericin B in prevention of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1993; 4: 211.
45. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20: 571-575.
46. Annaisie E, Bodey GP, Kantarjian H et al. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 1991; 91: 142-50.
47. Brammer KW. Management of fungal infection in neutropenic patients with fluconazole. Haematol Blood Transfusion 1990; 33: 546-550.
48. De Pauw B, Raemarks JMN, Donelly P, Kallberg B, Meis J. An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections. Ann Hematol 1995; 70: 83-87.
49. Rex J, and the Candidaemia Study Group and Infectious Diseases Mycoses Study Group: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidaemia in patients without neutropenia. N Engl J Med 1994; 331: 1325-1330.
50. Schmidt HJ. New methods of delivery of amphotericin B. Clin Infect Dis 1994; 2: 501-506.